FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085545 [Registered on: 24/04/2025] Trial Registered Prospectively
Last Modified On: 22/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   STUDY TO EVALUATE THE EFFECTIVENESS OF SWAYAMBHUVA GUGGULU AND SAPTAAMRITA LAUHA ALONG WITH NIMBA TAILA NASYA IN AKALA PALITYA  
Scientific Title of Study   A RANDOMIZED DOUBLE ARM COMPARATIVE CLINICAL STUDY TO ASSESS THE EFFICACY OF SWAYAMBHUVA GUGGULU AND SAPTAAMRITA LAUHA ALONG WITH NIMBA TAILA PRATIMARSHA NASYA IN AKALA PALITYA VIS-A-VIS PREMATURE CANITIES 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tejashwini D Sathale 
Designation  PG Scholar 
Affiliation  Ayurveda Mahavidyalaya and Hospital, Hubballi 
Address  Department of Kayachkitsa, OPD No. 1, Ayurveda Mahavidyalaya and Hospital, Heggeri Extension, Hubballi-580024

Dharwad
KARNATAKA
580024
India 
Phone  7348820043  
Fax    
Email  teja38136@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shivaji G Chavan 
Designation  Professor and Head of Department Kayachikitsa 
Affiliation  Ayurveda Mahavidyalaya and Hospital, Hubballi 
Address  Department of Kayachikitsa, OPD No. 1, Ayurveda Mahavidyalaya and Hospital, Heggeri Extension, Hubballi-580024

Dharwad
KARNATAKA
580024
India 
Phone  9448335479  
Fax    
Email  shivajichavan1671@gmil.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tejashwini D Sathale 
Designation  PG Scholar 
Affiliation  Ayurveda Mahavidyalaya and Hospital, Hubballi 
Address  Department of Kayachikitsa, OPD No. 1, Ayurveda Mahavidyalaya and Hospital, Heggeri Extension, Hubballi-580024

Dharwad
KARNATAKA
580024
India 
Phone  7348820043  
Fax    
Email  teja38136@gmail.com  
 
Source of Monetary or Material Support  
Ayurveda Mahavidyalaya and Hospital, Heggeri Extension, Hubballi- 580024 
 
Primary Sponsor  
Name  Dr. Tejashwini. D. Sathale 
Address  Ayurveda Mahavidyalaya and Hopsital, Heggeri Extension, Hubballi- 580024 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tejashwini Sathale  Ayurveda Mahavidyalaya and Hospital, Heggeri Extension, Hubballi-580024  Department of Kayachikitsa OPD no. 1 Ayurveda Mahavidyalaya Hubballi,Heggeri Extension, Old Hubli- 580024 Kanataka
Dharwad
KARNATAKA 
07348820043

teja38136@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethical Committee Clearance  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L679||Hair color and hair shaft abnormality, unspecified. Ayurveda Condition: AKALAPALITAH/PALITAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Swayambhuva Guggulu, Reference: Bhavaprakash, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Milk), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Saptaamrita lauha, Reference: Bhaisajya Ratnavali, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Milk), Additional Information: -
3Intervention ArmDrugClassical(1) Medicine Name: Nimba Taila, Reference: Bhaisajya Ratnavali, Route: Nasal, Dosage Form: Taila, Dose: 2(drops), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  1. Subjects having classical Signs and Symptoms of Akala Palitya like Kesha
Varna(Colour of hair), Rooksha Sphutita(dry split hair), Snigdha Sthoola(unctuous
thick hair), Daha (burning sensation).
2. Subjects within age group of 18-30 years irrespective of Gender and Occupation.
3. Subjects indicated for Nasya.
 
 
ExclusionCriteria 
Details  1. Subjects with Premature Canities as a part of other conditions such as Vitiligo,
Cutaneous disease involving the scalp and any of the Pre-diagnosed systemic
diseases.
2. Subjects with Pernicious Anaemia and any other Autoimmune diseases.
3. Subjects with Hormonal diseases and Hereditary disorders.
4. History of any hair dyeing within the previous one month.
5. Pregnant and lactating women.
6. Smoking. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To check the parameters as follows
SUBJECTIVE PARAMETERS
Premature change in the color of hair with one of the below symptoms
Dry splitted hair
Oilyness of hair
Burning sensation of scalp

OBJECTIVE PARAMETERS
Graying Severity Score11: The entire Scalp Surface is divided in 5 zones (Frontal, Vertex, Right
and Left Temporal Regions, Occipital). A 1cm2 area showing maximum graying is identified
and marked to count the number of white hair 
Total duration - 60 Days
 
 
Secondary Outcome  
Outcome  TimePoints 
To check the parameters as follows
SUBJECTIVE PARAMETERS
Premature change in the color of hair with one of the below symptoms
Dry splitted hair
Oilyness of hair
Burning sensation of scalp

OBJECTIVE PARAMETERS
Graying Severity Score11: The entire Scalp Surface is divided in 5 zones (Frontal, Vertex, Right
and Left Temporal Regions, Occipital). A 1cm2 area showing maximum graying is identified
and marked to count the number of white hair 
1st Follow up - 30th Day
2nd Follow up - 60th Day
 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Present study is a double arm clinical study with Pre-test and Post-test assessment. Minimum of 50 subjects diagnosed with Akala Palitya fulfilling the diagnostic and inclusion criteria will be incidentally selected and randomly categorized into two groups as Group A and Group B each consisting of 25 Subjects for the clinical study excluding the dropouts.
Sample Size: 50

Group A: 
 Sample Size  Minimum of 25 Subjects.    
 Amapachana  Shunti Choorna with Ushnaambu. 5gram Twice a Day, Before Food - Till Nirama Lakshana are seen.
 Nasya  Nimba Taila, Pratimarsha nasya (2 drops each nostrils) for 30 days.
 Shamana Aushadhi  Swayambhuva Guggulu with Milk as Anupana.
 Matra  500 mg, Twice a day, after food for 60 days.
 

GROUP B:
Sample Size  Minimum of 25 Subjects.    
 Amapachana  Shunti Choorna with Ushnaambu. 5gram Twice a Day, Before Food - Till Nirama Lakshana are seen.
 Nasya  Nimba Taila, Pratimarsha nasya (2 drops each nostrils) for 30 days.
 Shamana Aushadhi  Saptaamrita Lauha with Milk as Anupana.
 Matra  500 mg, Twice a day, after food for 60 days.

Follow up: 1. Follow up during the intervention: a. On 0th Day.
                                                                           b. On 30th Day. 
                                                                           c. On 60th day 
                  2. Follow up on completion of the intervention: On 75th day post treatment. 
PATHYAPATHYA: Subjects of both Groups will be advised Pathya Apathya. 
 
Close